دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
An Oncology Renaissance.
Friedberg, Jonathan W. MD, MMSc 1,2,3,,
doi : 10.1200/JCO.21.01649
Volume 39(25) pgs. 2737-2849 September 1, 2021
Contemporary Residential Segregation and Cancer Disparities.
Pleasant, Versha A. MD 1,2; Griggs, Jennifer J. MD, MPH 2,3,,
doi : 10.1200/JCO.21.01328
Harnessing the Therapeutic Value of Venetoclax: A Breakthrough Therapy in Acute Myeloid Leukemia.
Wei, Andrew H. MBBS, PhD 1,,; Roboz, Gail J. MD 2,; Kantarjian, Hagop M. MD 3,
doi : 10.1200/JCO.21.00080
Mortgage Lending Bias and Breast Cancer Survival Among Older Women in the United States.
Beyer, Kirsten M. M. PhD 1,2,3,; Zhou, Yuhong PhD 1; Laud, Purushottam W. PhD 1,2,3; McGinley, Emily L. MS, MPH 2; Yen, Tina W. F. MD, MS 2,3,4; Jankowski, Courtney MPH 1; Rademacher, Nicole MD 5; Namin, Sima PhD 1; Kwarteng, Jamila PhD 1,3,; Beltran Ponce, Sara MD 6; Nattinger, Ann B. MD, MPH 2,3,7
doi : 10.1200/JCO.21.00112
Ixazomib, Daratumumab, and Low-Dose Dexamethasone in Frail Patients With Newly Diagnosed Multiple Myeloma: The Hovon 143 Study.
Stege, Claudia A. M. MD 1,; Nasserinejad, Kazem PhD 2; van der Spek, Ellen MD, PhD 3,; Bilgin, Yavuz M. MD, PhD 4; Kentos, Alain MD, PhD 5,; Sohne, Maaike MD, PhD 6; van Kampen, Roel J. W. MD, PhD 7; Ludwig, Inge MD 8; Thielen, Noortje MD, PhD 9; Durdu-Rayman, Nazik MD, PhD 10; de Graauw, Nicole C. H. P. MD 11; van de Donk, Niels W. C. J. MD, PhD 1,; de Waal, Esther G. M. MD 12,; Vekemans, Marie-Christiane MD 13,; Timmers, Gert Jan MD, PhD 14,; van der Klift, Marjolein MD, PhD 15; Soechit, Savita MD 16; Geerts, Paul A. F. MD, PhD 17,; Silbermann, Matthijs H. MD 18; Oosterveld, Margriet MD, PhD 19; Nijhof, Inger S. MD, PhD 1,; Sonneveld, Pieter MD, PhD 20,; Klein, Saskia K. MD, PhD 21; Levin, Mark-David MD, PhD 22,; Zweegman, Sonja MD, PhD 1,
doi : 10.1200/JCO.20.03143
Venetoclax Combined With FLAG-IDA Induction and Consolidation in Newly Diagnosed and Relapsed or Refractory Acute Myeloid Leukemia.
DiNardo, Courtney D. MD, MSCE 1,,; Lachowiez, Curtis A. MD 2; Takahashi, Koichi MD, PhD 1,; Loghavi, Sanam MD 3,; Xiao, Lianchun MS 4; Kadia, Tapan MD 1,; Daver, Naval MD 1,; Adeoti, Maria RN 1; Short, Nicholas J. MD 1,; Sasaki, Koji MD 1,; Wang, Sa MD 3,; Borthakur, Gautam MD 1,; Issa, Ghayas MD 1,; Maiti, Abhishek MBBS 1,; Alvarado, Yesid MD 1,; Pemmaraju, Naveen MD 1,; Montalban Bravo, Guillermo MD 1,; Masarova, Lucia MD 1; Yilmaz, Musa MD 1,; Jain, Nitin MD 1,; Andreeff, Michael MD, PhD 1,; Jabbour, Elias MD 1,; Garcia-Manero, Guillermo MD 1,; Kornblau, Steven MD 1; Ravandi, Farhad MD 1,; Konopleva, Marina Y. MD, PhD 1,; Kantarjian, Hagop M. MD 1,
doi : 10.1200/JCO.20.03736
Survival Benefit for Individuals With Constitutional Mismatch Repair Deficiency Undergoing Surveillance.
Durno, Carol MD 1,2; Ercan, Ayse Bahar BSc 3,4; Bianchi, Vanessa PhD 3; Edwards, Melissa PhD 3; Aronson, Melyssa MSc 2; Galati, Melissa BSc 3,4; Atenafu, Eshetu G. MSc 5; Abebe-Campino, Gadi MD 6; Al-Battashi, Abeer MD 7; Alharbi, Musa MD 8; Azad, Vahid Fallah MD 9; Baris, Hagit N. MD 10,; Basel, Donald MD 11,; Bedgood, Raymond MD 12; Bendel, Anne MD 13; Ben-Shachar, Shay MD 14; Blumenthal, Deborah T. MD 15,; Blundell, Maude MSc 16; Bornhorst, Miriam MD 17,; Bronsema, Annika MD 18; Cairney, Elizabeth MD 19; Rhode, Sara MSc 20,; Caspi, Shani MD 21; Chamdin, Aghiad MD 22; Chiaravalli, Stefano MD 23; Constantini, Shlomi MD 24; Crooks, Bruce MD 25; Das, Anirban MD 26; Dvir, Rina MD 27; Farah, Roula MD 28,; Foulkes, William D. MD 29,; Frenkel, Zehavit MD 30; Gallinger, Bailey MSc 31; Gardner, Sharon MD 32; Gass, David MD 33,; Ghalibafian, Mithra MD 9; Gilpin, Catherine MSc 34; Goldberg, Yael MD 35; Goudie, Catherine MD 36; Hamid, Syed Ahmer MD 37; Hampel, Heather MSc 38,; Hansford, Jordan R. MD 39,; Harlos, Craig MD 40,; Hijiya, Nobuko MD 41,; Hsu, Saunders MD 42; Kamihara, Junne MD 43,; Kebudi, Rejin MD 44; Knipstein, Jeffrey MD 45,; Koschmann, Carl MD 46; Kratz, Christian MD 47; Larouche, Valerie MD 48; Lassaletta, Alvaro MD 49,; Lindhorst, Scott MD 50; Ling, Simon C. MD 1,; Link, Michael P. MD 51,; Loret De Mola, Rebecca MD 52,; Luiten, Rebecca MSc 53; Lurye, Michal MD 30; Maciaszek, Jamie L. PhD 54; MagimairajanIssai, Vanan MD 55; Maher, Ossama M. MD 56; Massimino, Maura MD 23,; McGee, Rose B. MSc 54; Mushtaq, Naureen MD 57; Mason, Gary MD 58,; Newmark, Monica MSc 59; Nicholas, Garth MD 60; Nichols, Kim E. MD 61,; Nicolaides, Theodore MD 32; Opocher, Enrico MD 62,; Osborn, Michael MD 63,; Oshrine, Benjamin MD 64,; Pearlman, Rachel MSc 65; Pettee, Daniel DO 66; Rapp, Jan 67; Rashid, Mohsin MD 68; Reddy, Alyssa MD 69,; Reichman, Lara MSc 70,; Remke, Marc MD 71,; Robbins, Gabriel MD 32; Roy, Sumita MD 72; Sabel, Magnus MD 73; Samuel, David MD 74; Scheers, Isabelle MD 75; Schneider, Kami Wolfe MSc 76,; Sen, Santanu MD 77; Stearns, Duncan MD 78,; Sumerauer, David MD 79; Swallow, Carol MD 80; Taylor, Leslie RN, BSN 54; Thomas, Gregory MD 81; Toledano, Helen MD 82; Tomboc, Patrick MD 83,; Van Damme, An MD 84,; Winer, Ira MD 72,; Yalon, Michal MD 6; Yen, Lee Yi MD 85; Zapotocky, Michal MD 86; Zelcer, Shayna MD 19; Ziegler, David S. MD 87,; Zimmermann, Stefanie MD 88; Hawkins, Cynthia MD 89,; Malkin, David MD 26,; Bouffet, Eric MD 26,; Villani, Anita MD 26; Tabori, Uri MD 26,
doi : 10.1200/JCO.20.02636
Clinicopathologic Features and Response to Therapy of NRG1 Fusion-Driven Lung Cancers: The eNRGy1 Global Multicenter Registry.
Drilon, Alexander MD 1,,; Duruisseaux, Michael MD 2,3,4,; Han, Ji-Youn MD, PhD 5,; Ito, Masaoki MD, PhD 6,7,8; Falcon, Christina MPH 1; Yang, Soo-Ryum MD 1,; Murciano-Goroff, Yonina R. MD, DPhil 9,; Chen, Haiquan MD, PhD 10,11; Okada, Morihito PhD 8,; Molina, Miguel Angel PhD 12,; Wislez, Marie MD, PhD 13,14,; Brun, Philippe MD 15; Dupont, Clarisse MD 2; Branden, Eva PhD 16,17; Rossi, Giulio MD, PhD 18,19; Schrock, Alexa PhD 20,; Ali, Siraj MD, PhD 20,; Gounant, Valerie MD 21,; Magne, Fanny MD 22; Blum, Torsten Gerriet MD 23; Schram, Alison M. MD 9,; Monnet, Isabelle MD 24,; Shih, Jin-Yuan MD, PhD 25,; Sabari, Joshua MD 26,; Perol, Maurice MD 27,; Zhu, Viola W. MD 28,; Nagasaka, Misako MD 29,30; Doebele, Robert MD, PhD 31; Camidge, D. Ross MD, PhD 31; Arcila, Maria MD 1; Ou, Sai-Hong Ignatius MD, PhD 32; Moro-Sibilot, Denis MD 33; Rosell, Rafael MD, PhD 34; Muscarella, Lucia Anna PhD 35; Liu, Stephen V. MD 36; Cadranel, Jacques MD 37
doi : 10.1200/JCO.20.03307
Randomized Phase II Study of PET Response-Adapted Combined Modality Therapy for Esophageal Cancer: Mature Results of the CALGB 80803 (Alliance) Trial.
Goodman, Karyn A. MD, MS 1,,; Ou, Fang-Shu PhD 2; Hall, Nathan C. MD, PhD 3; Bekaii-Saab, Tanios MD 4,; Fruth, Briant MS 2; Twohy, Erin MS 2; Meyers, Michael O. MD 5; Boffa, Daniel J. MD 6,; Mitchell, Kisha MD 7; Frankel, Wendy L. MD 8,; Niedzwiecki, Donna PhD 9; Noonan, Anne MD 8,; Janjigian, Yelena Y. MD 10,; Thurmes, Paul J. MD 11,; Venook, Alan P. MD 12,; Meyerhardt, Jeffrey A. MD 13,; O'Reilly, Eileen M. MD 10,; Ilson, David H. MD, PhD 10,
doi : 10.1200/JCO.20.03611
Randomized Study on Dose Escalation in Definitive Chemoradiation for Patients With Locally Advanced Esophageal Cancer (ARTDECO Study).
Hulshof, Maarten C. C. M. MD, PhD 1,; Geijsen, Elisabeth D. MD 1; Rozema, Tom MD 2; Oppedijk, Vera MD 3; Buijsen, Jeroen MD, PhD 4; Neelis, Karen J. MD, PhD 5; Nuyttens, Joost J. M. E. MD, PhD 6; van der Sangen, Maurice J. C. MD, PhD 7; Jeene, Paul M. MD 8; Reinders, Jannie G. MD 9; van Berge Henegouwen, Mark I. MD, PhD 10,; Thano, Adriana PhD 11; van Hooft, Jeanin E. MD, PhD 12,; van Laarhoven, Hanneke W. M. MD, PhD 13,; van der Gaast, Ate MD, PhD 14
doi : 10.1200/JCO.20.03697
Salivary Gland Hypofunction and/or Xerostomia Induced by Nonsurgical Cancer Therapies: ISOO/MASCC/ASCO Guideline.
Mercadante, Valeria BDS, PhD 1; Jensen, Siri Beier DDS, PhD 2; Smith, Derek K. DDS, PhD, MPH 3; Bohlke, Kari ScD 4; Bauman, Jessica MD 5,; Brennan, Michael T. DDS, MHS 6,; Coppes, Robert P. PhD 7; Jessen, Niels 8,; Malhotra, Narinder K. MD 9; Murphy, Barbara MD 3,; Rosenthal, David I. MD 10,; Vissink, Arjan DDS, MD, PhD 11,; Wu, Jonn MD 12,; Saunders, Deborah P. DMD 13; Peterson, Douglas E. DMD, PhD 14,
doi : 10.1200/JCO.21.01208
Is Distant Metastasis-Free Survival Lead Time Bias?.
Olson, Adam C. MD, MS; Beriwal, Sushil MD, MBA
doi : 10.1200/JCO.21.00326
End Point Definitions and Surrogacy in Prostate Cancer: Will Metastasis-Free Survival Become Event-Free Survival With Advances in Molecular Imaging?.
Dess, Robert T. MD; Jackson, William C. MD; Spratt, Daniel E. MD
doi : 10.1200/JCO.21.00376
Elective Pelvic Lymph Node Radiation in Prostate Cancer Revisited.
Yang, David D. MD; Nguyen, Paul L. MD; D'Amico, Anthony V. MD, PhD
doi : 10.1200/JCO.21.00621
Regarding the Use of PSMA PET-CT Versus Conventional Imaging for Assessing the Value of Prophylactic Whole-Pelvis Radiation for High-Risk Prostate Cancer.
Brenneman, Randall J. MD, PhD; Baumann, Brian C. MD; Gay, Hiram A. MD; Michalski, Jeff M. MD, MBA
doi : 10.1200/JCO.21.00634
Reply to A.C. Olson et al, R.T. Dess et al, D.D. Yang et al, and R.J. Brenneman et al.
Murthy, Vedang MD; Maitre, Priyamvada MD
doi : 10.1200/JCO.21.00810
